Literature DB >> 11700539

Tackling anthrax.

A M Friedlander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700539     DOI: 10.1038/35102660

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  18 in total

1.  X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.

Authors:  Brad C Bennett; Qun Wan; Md Faiz Ahmad; Paul Langan; Chris G Dealwis
Journal:  J Struct Biol       Date:  2009-05       Impact factor: 2.867

2.  Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.

Authors:  Steven M Opal; Andrew W Artenstein; Patricia A Cristofaro; Jhung W Jhung; John E Palardy; Nicholas A Parejo; Yow-Pin Lim
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 3.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

4.  Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Mahtab Moayeri; Stephen H Leppla; Sergey M Bezrukov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-07       Impact factor: 11.205

5.  Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Adiamseged Yohannes; Tanisha M Robinson; Nour Eddine Fahmi; Frank Schmidtmann; Sidney M Hecht; Sergey M Bezrukov
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

Review 6.  Anthrax infection.

Authors:  Daniel A Sweeney; Caitlin W Hicks; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

Review 7.  An overview of anthrax infection including the recently identified form of disease in injection drug users.

Authors:  Caitlin W Hicks; Daniel A Sweeney; Xizhong Cui; Yan Li; Peter Q Eichacker
Journal:  Intensive Care Med       Date:  2012-04-24       Impact factor: 17.440

8.  Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination.

Authors:  Sha Cao; Aizhen Guo; Ziduo Liu; Yadi Tan; Gaobing Wu; Chengcai Zhang; Yaxing Zhao; Huanchun Chen
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

9.  SAR studies for a new class of antibacterial NAD biosynthesis inhibitors.

Authors:  Whitney Beysselance Moro; Zhengrong Yang; Tasha A Kane; Qingxian Zhou; Steve Harville; Christie G Brouillette; Wayne J Brouillette
Journal:  J Comb Chem       Date:  2009 Jul-Aug

10.  Exploring the Nature of Cationic Blocker Recognition by the Anthrax Toxin Channel.

Authors:  Sanaz Momben Abolfath; Michelle Kolberg; Vladimir A Karginov; Stephen H Leppla; Ekaterina M Nestorovich
Journal:  Biophys J       Date:  2019-09-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.